胰腺
医学
神经内分泌肿瘤
放射科
倾向得分匹配
核医学
回顾性队列研究
内科学
胃肠病学
作者
Fang Liu,Jing Li,Xu Fang,Yinghao Meng,Hao Zhang,Jieyu Yu,Xiaochen Feng,Li Wang,Hui Jiang,Jianping Lu,Yun Bian,Chengwei Shao
标识
DOI:10.1016/j.acra.2021.02.020
摘要
To evaluate the diagnostic performance of the delayed-phase difference between tumor and pancreas for differentiating solid pseudopapillary tumors (SPTs) from non-functional neuroendocrine tumors (NF-NETs) of the pancreas.This retrospective review included 148 consecutive patients with SPT and 98 consecutive patients with NF-NET confirmed by pathology. Patients with SPT and NF-NET were matched via propensity score matching (PSM). All patients underwent multidetector computed tomography (MDCT). For each patient, the delayed-phase difference between the tumor and pancreas was measured, and the performance of this variable was assessed based on its discriminative ability and clinical utility.After PSM, 27 patients with SPT and 27 patients with NF-NET were included in the matched analysis. There were no statistically significant differences in clinical and CT characteristics between the resulting two groups (p > 0.05). The delayed-phase difference values between the tumor and pancreas were significantly lower in patients with SPT (median: -0.45; range: -2.05 to 0.73) than in patients with NF-NET (median: 0.71; range: -1.39 to 2.38). The delayed-phase difference between tumor and pancreas had a high diagnostic accuracy (area under the curve=0.88). The best cutoff point based on maximizing the sum of the sensitivity and specificity was -0.23 (sensitivity = 88.89%; specificity = 88.89%; accuracy = 0.89).The delayed-phase difference between tumor and pancreas can accurately and noninvasively differentiate SPT from NF-NET.
科研通智能强力驱动
Strongly Powered by AbleSci AI